Yes intravitreal clearly better, AVA-201 is intravitreal. 201 is supposed to use a next-gen vector and they also talk about directed vector evolution, AAVL have a license with UC for that.
Makes me even more inclined to await further data on 101 before considering AAVL as sounds like 201 might be a better drug (I know going after wet AMD prevention versus treatment with 101 so a bit different).